Pioneering scientist whose breakthrough studies of chimpanzees changed how the animals were perceived and led to greater protection.

The industry’s retreat from the UK reflects a deeper shift about how Beijing is rewriting the rules of innovation.

Divisions are growing within the European Parliament over plans to let research and innovation projects with civilian and defence applications apply for funding in the next EU Framework Programme. 

In exchange for continued taxpayer funding, American universities must better explain how research promotes the well-being and security of the public, according to two of the country’s top leaders in science policy.

These partnerships accelerate neuroscience by enabling researchers to share resources and expertise, as well as generate more relevant and reproducible results. But new federal funding restrictions in the United States are putting such collaborations in jeopardy.

Between January 20th and August 31st 2025, there have been 479 attacks on science, which undermine, co-opt, or blatantly ignore science in the federal government. These attacks follow the plan laid out in Project 2025.

The global focus on what equitable access to and success in higher education means needs to be rebalanced.

Commercialisation has thwarted the promise of openness—it’s time for new priorities, says Samuel Moore

Five large-scale problems that new security policies for the public research sector will encounter.

Brussels research lobbies, together with leading MEP Christian Ehler, are calling for more detail and clarity about the European Commission's €175 billion plan for the tenth Framework Programme (FP10).

With a boost from the Trump administration, organ chips, AI, and other technologies bid to replace animals for drug and chemical testing.

GenAI in science: The unexploited opportunity.

For science diplomacy to remain relevant in this era, it must develop a new mode of engagement—transactional science diplomacy.

The avian flu virus is now just one mutation away from easier transmission among humans. Donald Trump’s health chief is a grave risk to world health.

We know from other countries and contexts that aspiring authoritarians often target scientists, elevate loyalists, and suppress or sideline any who might have the knowledge, expertise, or power to challenge government transgression and failures to make science-based policy decisions. In response to such threats, the US scientific community can work to rebuild critical elements of the federal science enterprise now being dismantled or compromised, including science advisory committees and scientific assessments, which for decades have helped ensure that the best available science informs policy decisions.